Chris Ziobro

Chris Ziobro has a diverse work experience that spans various roles and industries. Chris began their career as a Chemical Engineer Co-op at Forest Laboratories in 2001. From there, they worked as a Six Sigma Intern at The Dow Chemical Company in 2002. Chris then served as an Undergraduate Research Assistant at Case Western Reserve University, where they worked under Professor Jeffrey T. Glass, Ph.D. This position lasted from 2002 to 2003.

In 2003, Chris joined DUPONT SPECIALTY CHEMICALS as a Chemical Engineer Co-op for a short period before transitioning to Wyeth as a Biochemical Engineer from 2004 to 2005. Chris then joined BRISTOL-MYERS SQUIBB Co as a Project Management Specialist, where they worked from 2005 to 2011.

In 2011, Chris moved to ReSearch Pharmaceutical Services as a Senior Protocol Project Manager RPS-Merck Insourcing until 2012. Chris then joined Merck as a Clinical Supply Program Manager from 2012 to 2018. Following that, they were promoted to Associate Director-Global Clinical Supplies, a position they held from 2018 to 2021.

In 2021, Chris joined Zentalis Pharmaceuticals as the Director- Clinical Supply Operations, a role they occupied until 2022. Currently, they hold the position of Director- Manufacturing and Supply at Apnimed, starting in August 2022.

Throughout their career, Chris has gained significant experience in various aspects of manufacturing and supply in the pharmaceutical industry.

Chris Ziobro earned a Bachelor of Science degree in Chemical Engineering from Case Western Reserve University between 1999 and 2004. Chris then pursued further education at NYU Stern School of Business, where they obtained an MBA in Finance and Strategy from 2008 to 2011.